Nasal Congestion News and Research

RSS

NACCHO to donate up to one million doses of FluMist

The National Association of County and City Health Officials (NACCHO) has announced a donation of up to one million doses of FluMist (Influenza Virus Vaccine Live, Intranasal) by MedImmune in a partnership aimed at increasing influenza awareness and vaccinations in underserved communities and populations.

14 Dec 2008

FDA approves Rapaflo for treatment of symptoms due to benign prostatic hyperplasia

The U.S. Food and Drug Administration today approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also known as an enlarged prostate.

12 Oct 2008

Science backs old fashioned belief in the healing powers of honey

Research by Canadian scientists lends support to the old fashioned belief in the healing powers of honey.

25 Sep 2008

Garlic supplements may help control high blood pressure

According to a new review of relevant research, garlic supplements may be as effective at lowering blood pressure as some hypertension drugs.

4 Aug 2008

Nasal irrigation can relieve sinus symptoms safely, cheaply

Your spring cleaning routine might include vacuuming the coils on your refrigerator and storing bulky sweaters and corduroy pants. You may want to add to that list, according to a University of Michigan Health System expert, another area that could use some cleaning.

7 Apr 2008

Antibiotics may be of little use in treating sinus infections

A new British study disputes the effectiveness of antibiotic drugs prescribed to treat sinus infections.

6 Dec 2007

FDA approves formulations of Zyrtec (cetirizine HCl) for nonprescription use

The U.S. Food and Drug Administration has approved tablet, chewable tablet, and syrup formulations of Zyrtec (cetirizine HCl) for nonprescription use.

21 Nov 2007

FDA approves new nonprescription allergy drug Zyrtec-D

The Food and Drug Administration (FDA) has approved Zyrtec-D (cetirizine HCl 5 mg and pseudoephedrine HCl 120 mg), an allergy drug, for nonprescription use in adults and children 12 years of age and older. This drug combines an antihistamine with a nasal decongestant.

13 Nov 2007

Survival data presented from phase II study of hormone-resistant prostate cancer patients

The results from the randomized, double -blind, placebo -controlled, Phase II EPOC (Endothelin A Proof Of Concept) Study of ZD4054 - a specific endothelin A (ETA) receptor antagonist – were delivered at the 14th European Congress of Clinical Oncology (ECCO, 23-27 September, Barcelona).

26 Sep 2007

New AstraZeneca compound shows promoise for hormone resistant prostate cancer patients with bone metastases

New Phase II data suggests that ZD4054, a novel compound in development for the treatment of men with Hormone Resistant Prostate Cancer (HRPC), could offer a promising improvement in overall survival in men with metastatic HRPC who were asymptomatic or mildly symptomatic for pain.

26 Sep 2007

FDA expands use of influenza vaccine FluMist

The U.S. Food and Drug Administration has approved expanding the population for use of the nasal influenza vaccine FluMist to include children between the ages of 2 and 5.

20 Sep 2007

Asthma and allergic shock

Asthma, even a mild form, is the single most important factor that increases the risk of death from anaphylaxis (allergic shock), says a new report from Harvard Medical School, What To Do About Allergies .

14 Jun 2007

FDA completes review of FluMist

MedImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review of all submissions made related to the supplemental biologics license application (sBLA) to extend the age indication of FluMist (Influenza Virus Vaccine Live, Intranasal).

28 May 2007

FluMist may help reduce the burden of seasonal influenza

MedImmune, Inc. has announced research results showing that use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) in daycare and school settings may help reduce the burden of seasonal influenza.

9 May 2007

Steroids for acute sinusitis

Every year, nearly 37 million Americans suffer from the sinus pressure, nasal congestion, cough and postnasal drip that accompany sinusitis.

19 Apr 2007

Prazosin drug helps posttraumatic stress disorder nightmares

A generic drug already used by millions of Americans for high blood pressure and prostate problems has been found to improve sleep and lessen trauma nightmares in veterans with posttraumatic stress disorder (PTSD).

12 Apr 2007

Sleep apnea linked to heart disease

New research in the U.S. suggests that people who suffer from sleep apnea have an increased risk of heart disease.

5 Mar 2007

FDA approves Omnaris, new hay fever drug

The U.S. Food and Drug Administration (FDA) has announced the approval of Omnaris (ciclesonide) nasal spray, a new drug for the treatment of nasal symptoms associated with seasonal and perennial allergic rhinitis, commonly known as hay fever, in adults and children 12 years of age and older.

23 Oct 2006

Over-the-counter decongestant as good as prescription drug in relieving hay fever symptoms

There is no significant difference between an over-the-counter decongestant and a prescription medication that costs almost four times as much in relieving hay fever symptoms, report researchers from the University of Chicago in the February issue of Archives of Otolaryngology - Head & Neck Surgery.

24 Feb 2006

Two common weight loss supplements promoted as ephedra-free and safe for dieters caused increased heart rate among healthy people

...and could have harmful health effects in some people, according to a study by University of California - San Francisco (UCSF) scientists. Their placebo-controlled clinical study is the first to examine the pharmacological effects of these re-formulated dietary supplements.

10 Sep 2005